Chemotherapy for patients with pulmonary Kaposi's sarcoma: benefit of filgrastim (G-CSF) in supporting dose administration.

Sloand, E

Chemotherapy for patients with pulmonary Kaposi's sarcoma: benefit of filgrastim (G-CSF) in supporting dose administration. [electronic resource] - Southern medical journal Nov 1993 - 1219-24 p. digital

Publication Type: Journal Article

0038-4348

10.1097/00007611-199311000-00006 doi


Antineoplastic Combined Chemotherapy Protocols--adverse effects
Filgrastim
Granulocyte Colony-Stimulating Factor--therapeutic use
Humans
Lung Neoplasms--drug therapy
Neutropenia--chemically induced
Recombinant Proteins--therapeutic use
Sarcoma, Kaposi--drug therapy
Survival Analysis
Treatment Outcome